By signing the Copyright Letter the authors retain the rights of self-archiving. Following are the important features of self-archiving policy of Bentham Science journals:
Authors can deposit the first draft of a submitted article on their personal websites, their institution’s repositories or any non-commercial repository for personal use, internal institutional use or for permitted scholarly posting.
Authors may deposit the ACCEPTED VERSION of the peer-reviewed article on their personal websites, their institution’s repository or any non-commercial repository such as PMC, arXiv after 12 MONTHS of publication on the journal website. In addition, an acknowledgement must be given to the original source of publication and a link should be inserted to the published article on the journal's/publisher’s website.
If the research is funded by NIH, Wellcome Trust or any other Open Access Mandate, authors are allowed the archiving of published version of manuscripts in an institutional repository after the mandatory embargo period. Authors should first contact the Editorial Office of the journal for information about depositing a copy of the manuscript to a repository. Consistent with the copyright agreement, Bentham Science does not allow archiving of FINAL PUBLISHED VERSION of manuscripts.
The link to the original source of publication should be provided by inserting the DOI number of the article in the following sentence: “The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/openurl/content.php?genre=article&doi=[insert DOI].”
There is no embargo on the archiving of articles published under the OPEN ACCESS PLUS category. Authors are allowed deposition of such articles on institutional, non-commercial repositories and personal websites immediately after publication on the journal website.
Imran Ali Jamia Millia Islamia (Central University) New Delhi India
Prof. Imran Ali, PhD, FRSC (UK) is a full Professor at Jamia Millia Islamia Central University, India. He has 25 years of experience in the research, discovery and development of chiral and anti cancer drugs development. He has more than 350 publications including five books and two patents, with total citations more than 10000, 41 h-index and 136 i10-index. He member of RSC, UK and ACS, USA. He has been visiting Professor at KSU Riyadh, SQU, Muscat Oman, UTM, Johor, Malaysia. He is on Editorial Board Member of 10 National and International Journals. He is a reviewer of more than 50 National and International Journals.